Our study reveals that the loss of CDX2 function in GC may be attributed to promoter hypermethylation, and that the reactivation of CDX2 by 5-aza-CdR inhibits cell proliferation and induces caspase-3-independent apoptosis in GC cells. The gene discussed is CASP3; the disease is gastric cancer.